论文部分内容阅读
为做好复方甘草片(改方)的生产管理工作,使各定点生产厂按照卫药政字(90)第51号文件的精神切实加强对复方甘草片的生产管理,中国医药工业公司、卫生部药政局于1991年4月22至25日在深圳联合召开了“复方甘草片(改方)生产管理会议,会上中国医药工业公司计划处关启昱处长总结了自1989年正式批准青海药厂生产复方甘草片(改方)以来,卫生部药政局到目前为止已分两批批准了十九个制药厂为复方甘草片定点生产单位,绝大部分定点厂已按卫药政字(90)第51号文件的要
In order to do a good job in the production and management of compound licorice tablets (reformed side), all fixed-point production plants should conscientiously strengthen the production and management of compound licorice tablets in accordance with the spirit of the Government Pharmacopoeia (90) No.51, and China Pharmaceutical Industry Corporation, Department of Pharmaceutical Affairs in April 22, 1991 to 25 in Shenzhen jointly held a "compound licorice tablets (reform) production management conference, the meeting of the China Pharmaceutical Industry Corporation Planning Department Commissioner Kai-Yu Yu concluded in 1989 formally approved the Qinghai Pharmaceutical Factory Since the production of Compound Licorice Tablets (Modified Prescription), the Pharmaceutical Administration of the Ministry of Health has so far approved 19 manufacturing plants for compound licorice tablets in two batches, with the vast majority of designated plants already producing medicinal herbs (90) Document No. 51